BAX and cancer: In functional p53-expressing cancer cells, crocetin targets p53-mediated BAX activation in one hand and PIDD/caspase-2-mediated BID activation on the other which together converge to mitochondria to cause transmembrane permeability loss and caspase cascade activation.